Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Hypernatremia during lithium and ticarcillin therapy.

R A Finch

    Southern Medical Journal
    |March 1, 1981
    PubMed
    Summary
    This summary is machine-generated.

    Lithium carbonate and ticarcillin, used for sepsis in leukemia patients, can cause dangerous hypernatremia and polyuria. Careful monitoring is crucial when these medications are used together.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    The karyotype of tuleen 346 barley.

    TAG. Theoretical and applied genetics. Theoretische und angewandte Genetik·2013
    Same author

    High-throughput mouse knockouts provide a functional analysis of the genome.

    Cold Spring Harbor symposia on quantitative biology·2004
    Same author

    Transport of fluorescein in MDCKII-MRP1 transfected cells and mrp1-knockout mice.

    Biochemical and biophysical research communications·2001
    Same author

    Optimization of an exogenous metabolic activation system for FETAX. I. Post-isolation rat liver microsome mixtures.

    Drug and chemical toxicology·2001
    Same author

    Optimization of an exogenous metabolic activation system for FETAX. II. Preliminary evaluation.

    Drug and chemical toxicology·2001
    Same author

    1,2-Bis(methylsulfonyl)-1-(2-chloroethyl)-2-(methylamino)carbonylhydrazine (101M): a novel sulfonylhydrazine prodrug with broad-spectrum antineoplastic activity.

    Cancer research·2001
    Same journal

    SMA's 6th Annual Physicians-in-Training Leadership Conference Abstract Presentations.

    Southern medical journal·2026
    Same journal

    Potential Impact of Lower Federal Loan Availability on Medical Education in Appalachia.

    Southern medical journal·2026
    Same journal

    Experiential Mentorship Skills Training: The Effect on Real-Life Mentoring.

    Southern medical journal·2026
    Same journal

    Social Pressure: How Early Social Context Shapes Career Interest in Medicine.

    Southern medical journal·2026
    Same journal

    Comparing Speed and Accuracy of Artificial Intelligence Large Language Models on the Orthopedic In-Training Examination.

    Southern medical journal·2026
    Same journal

    Don't Wait to Talk about Weight: A 2-Hour Interactive Curriculum Improves Medical Student Skills with Weight Management.

    Southern medical journal·2026
    See all related articles

    Area of Science:

    • Nephrology
    • Oncology
    • Pharmacology

    Background:

    • Leukemia treatment often involves managing complications like sepsis.
    • Lithium carbonate and ticarcillin are used in specific clinical scenarios.

    Observation:

    • A patient undergoing leukemia treatment developed polyuria and severe hypernatremia.
    • These symptoms emerged after the administration of lithium carbonate and ticarcillin for sepsis.

    Findings:

    • The co-administration of lithium carbonate and ticarcillin was associated with the development of severe hypernatremia and polyuria.
    • This drug combination, while beneficial in neutropenic patients, carries a risk of life-threatening electrolyte imbalance.

    Implications:

    • Clinicians should exercise caution when prescribing lithium carbonate and ticarcillin concurrently.

    Related Experiment Videos

  • Enhanced patient monitoring for hypernatremia and polyuria is recommended in such cases.
  • Understanding potential drug interactions is vital for patient safety in oncology and critical care settings.